Université de la Réunion, Inserm, UMR 1188 Diabète athérothrombose Thérapies Réunion Océan Indien (DéTROI), Sainte-Clotilde, F-97490, France.
Centre hospitalier Gabriel Martin, Saint Paul, France.
Atherosclerosis. 2019 Dec;291:87-98. doi: 10.1016/j.atherosclerosis.2019.10.015. Epub 2019 Oct 26.
Atherothrombotic plaques of type 2 diabetic (T2D) patients are characterized by an increased neovascularization and intraplaque hemorrhage. The clearance of erythrocytes may be carried out by vascular cells. We explored the potential of human endothelial cells to bind and phagocyte in vitro aged and/or glycated erythrocytes as well as erythrocytes obtained from diabetic patients.
Fresh, aged and glycated-aged erythrocytes from healthy volunteers and T2D patients were tested for their binding and phagocytosis capacity as well as the potential functional consequences on endothelial cells (viability, proliferation and wound healing capacity). Immunohistochemistry was also performed in human carotid atherothrombotic samples (from patients with or without T2D).
Aging and glycation of erythrocytes induced phosphatidylserine (PS) exposure and oxidative stress leading to enhanced endothelial cell binding and engulfment. Phagocytosis by endothelial cells was more pronounced with aged and glycated erythrocytes than with fresh ones. Phagocytosis was enhanced with T2D versus healthy erythrocytes. Furthermore, endothelial wound healing potential was significantly blunted after exposure to glycated-aged versus fresh erythrocytes. Finally, we show that interactions between erythrocytes and endothelial cells and their potential phagocytosis may occur in vivo, in atherothrombotic conditions, in neovessels and in the luminal endothelial lining.
Endothelial cells may play an important role in erythrocyte clearance in an atherothrombotic environment. Under diabetic conditions, erythrocyte glycation favors their engulfment by endothelial cells and may participate in endothelial dysfunction, thereby promoting vulnerable atherothrombotic plaques to rupture.
2 型糖尿病(T2D)患者的动脉粥样硬化斑块的特点是新生血管增加和斑块内出血。红细胞的清除可能是由血管细胞完成的。我们探讨了人内皮细胞在体外结合和吞噬衰老和/或糖化的红细胞以及来自糖尿病患者的红细胞的潜力。
来自健康志愿者和 T2D 患者的新鲜、衰老和糖化衰老的红细胞,其结合和吞噬能力以及对内皮细胞(活力、增殖和伤口愈合能力)的潜在功能后果进行了测试。还对人类颈动脉粥样硬化标本(来自有或没有 T2D 的患者)进行了免疫组织化学分析。
红细胞的衰老和糖化导致磷脂酰丝氨酸(PS)暴露和氧化应激,从而增强了内皮细胞的结合和吞噬作用。与新鲜红细胞相比,衰老和糖化的红细胞更能被内皮细胞吞噬。与健康红细胞相比,T2D 红细胞的吞噬作用增强。此外,暴露于糖化衰老红细胞后,内皮细胞的伤口愈合能力显著减弱。最后,我们表明,红细胞与内皮细胞之间的相互作用及其潜在的吞噬作用可能在体内、动脉粥样硬化环境中、新生血管中和管腔内皮衬里中发生。
内皮细胞在动脉粥样硬化环境中的红细胞清除中可能发挥重要作用。在糖尿病条件下,红细胞糖化有利于内皮细胞吞噬,并可能参与内皮功能障碍,从而促进易损的动脉粥样硬化斑块破裂。